Center for Innovation & Value Research的动态

Insights on the importance of effective HCP education in launching successful pharma products with a strong uptake and maximal peak sales. It’s vital to ensure that healthcare professionals are equipped with the right knowledge to better serve patients. A good launch strategy can make all the difference!

Pharmaceutical Launch Leaders, are you making enough noise in your target market? At Trilations, we delve into the influence of familiarity on launch success in different regions and therapeutic areas to help your team navigate this critical driver of success. Understanding the role of product familiarity can be crucial for a successful global drug launch. This crucial first step of achieving a high product familiarity is key for a strong adoption in the market. During our recent Launch webinar Douglas Black underlined the importance of 'getting it right' from the beginning: "A drug approval is like a unicorn. It's very precious, not only to the company but most importantly to the patient, and you have to get it right." Learn from Michiel Dockx, Launch Excellence Lead at Trilations, his key findings and strategies are invaluable to leverage HCPs' familiarity with new brands for a more impactful launch. Discover the steps you can take to ensure your product resonates with the target market and achieves its full potential on a global and regional scale. Get in contact with Michiel: https://loom.ly/9lNWHLY In this whitepaper our Launch Excellence Lead, Michiel, dives into key findings and strategies that are invaluable to leverage awareness for a more impactful launch. Discover the insights here: https://loom.ly/1dcv2EE This is part 1 of Trilations' Pharma Launch Excellence series. Save this post and make sure to see the following insights. #Pharma #Trilationslaunch #hcpeducation #patientcare #productawareness #launchexcellence

Part 2 of my newsletter on the power of the Target Product Profile. This month I review three real-world cases. See if you can guess which companies and products are described!

This month, as promised, James Whalen (he/him/his) continues the discussion on the Target Product Profile (TPP) with 3 real-world examples of how our clients have used them in practice. https://lnkd.in/e3GSccYt By incorporating TPPs from the start, companies can effectively steer their products toward successful market entry and meet unmet patient needs. #biopharma #DrugDevelopment #TargetProductProfile #commercialization

The article discusses how device-enabled digital health solutions can create new business opportunities for pharmaceutical companies by addressing core problems and leveraging integrated solutions.

PHARAONIA Pharmaceuticals and Delta Pharma Access teams, Rocked the day after joining forces in an interactive workshop to explore the challenges and opportunities in the private reimbursement sector.?? ? During the workshop we shared our views on market dynamics, conducted a 360 degrees macro-environmental analysis, revisited market trends & updates and brainstormed innovative ideas to enhance patient access, capture market opportunities and deliver disruptive scalable solutions in an accelerated momentum with a vision of reaching every patient in desperate need of high quality cost-effective medications. ? Stay tuned for upcoming workshop outcomes. ? ? #Transform_today_shape_tomorrow

Prasanna Kumar Subbanna will be joining us at #TheMachinecon2024. He is a seasoned physician and business executive with over two decades of distinguished experience in the healthcare and pharmaceutical R&D sectors. With a profound understanding of the global value chain, his expertise spans clinical development, product launches, and bedside care, underscoring a comprehensive approach to healthcare innovation and patient outcomes. He will share his insights on "The Role of #GCCs in Healthcare Innovation" in an interesting panel Discussion. Novo Nordisk

?????? Getting a strong uptake after market entry is crucial for any pharma drug to become successful in a competitive environement. An essential prerequisite to achieve this is to inform and educate your target customers about your product well upfront, making them set realistic standards for when they would starting to prescribe your product. At Trilations Healthcare Strategies, we draw insights from a global database of HCPs' perceptions of over 300 launches in the past 5 years. Interested to learn more? Feel free to contact me via a personal message. #pharma #drugs #launch

PHARAONIA Pharmaceuticals and Delta Pharma Access teams, Rocked the day after joining forces in an interactive workshop to explore the challenges and opportunities in the private reimbursement sector.?? ? During the workshop we shared our views on market dynamics, conducted a 360 degrees macro-environmental analysis, revisited market trends & updates and brainstormed innovative ideas to enhance patient access, capture market opportunities and deliver disruptive scalable solutions in an accelerated momentum with a vision of reaching every patient in desperate need of high quality cost-effective medications. ? Stay tuned for upcoming workshop outcomes. ? ? #Transform_today_shape_tomorrow

There are key drivers to launch success, the first of which is product familiarity. Measuring it in a competitive way, and against benchmarks, is even more insightful and something you can't afford not to do when a key product launch is your responsibility. #pharmamarketing #pharma #launchexcellence